Latigo Biotherapeutics, Inc.
$13.37
Mkt Cap 886.1M
Developer of non-opioid pain medicines that target pain at its source before it reaches the central nervous system.
latigobio.com ↗Summary by The Compound Family, based on the company’s own website
—
/100 Overall
Calculating score…
Running full analysis
Ready to value this company?
Run a full DCF model with Monte Carlo simulation.
Run DCF Valuation →
Run a full DCF model with Monte Carlo simulation.
Key Metrics
Loading full analysis…
Running full 6-factor analysis…